{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:50:39Z","timestamp":1792763439986,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/onc.2017.349","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T14:59:02Z","timestamp":1506956342000},"page":"478-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1\u2013TSC2 complex"],"prefix":"10.1038","volume":"37","author":[{"given":"P","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Huai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"key":"BFonc2017349_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei B, Rotman Y, Ditah I, Lim JK . Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 2015; 61: 191\u2013199.","journal-title":"Hepatology"},{"key":"BFonc2017349_CR2","first-page":"135","volume":"16","author":"M Watanabe","year":"2017","unstructured":"Watanabe M, Hatakeyama S . TRIM proteins and diseases. J Biochem 2017; 16: 135\u2013144.","journal-title":"J Biochem"},{"key":"BFonc2017349_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/15384101.2014.1000112","volume":"14","author":"L Kozakova","year":"2015","unstructured":"Kozakova L, Vondrova L, Stejskal K, Charalabous P, Kolesar P, Lehmann AR et al. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex. Cell Cycle 2015; 14: 920\u2013930.","journal-title":"Cell Cycle"},{"key":"BFonc2017349_CR4","doi-asserted-by":"publisher","first-page":"13727","DOI":"10.1038\/ncomms13727","volume":"7","author":"H Song","year":"2016","unstructured":"Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun 2016; 7: 13727.","journal-title":"Nat Commun"},{"key":"BFonc2017349_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/CBI20100772","volume":"35","author":"T Sugiura","year":"2011","unstructured":"Sugiura T . The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system. Cell Biol Int 2011; 35: 657\u2013661.","journal-title":"Cell Biol Int"},{"key":"BFonc2017349_CR6","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/jcb.21908","volume":"105","author":"T Sugiura","year":"2008","unstructured":"Sugiura T, Miyamoto K . Characterization of TRIM31, upregulated in gastric adenocarcinoma, as a novel RBCC protein. J Cell Biochem 2008; 105: 1081\u20131091.","journal-title":"J Cell Biochem"},{"key":"BFonc2017349_CR7","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1007\/s13277-014-1763-x","volume":"35","author":"H Li","year":"2014","unstructured":"Li H, Zhang Y, Bai X, Peng Y, He P . TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor. Tumour Biol 2014; 35: 5747\u20135752.","journal-title":"Tumour Biol"},{"key":"BFonc2017349_CR8","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1038\/ncomms11726","volume":"7","author":"EA Ra","year":"2016","unstructured":"Ra EA, Lee TA, Won Kim S, Park A, Choi HJ, Jang I et al. TRIM31 promotes Atg5\/Atg7-independent autophagy in intestinal cells. Nat Commun 2016; 7: 11726.","journal-title":"Nat Commun"},{"key":"BFonc2017349_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM . mTOR signaling in growth, metabolism, and disease. Cell 2017; 168: 960\u2013976.","journal-title":"Cell"},{"key":"BFonc2017349_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00109-011-0726-6","volume":"89","author":"JL Yecies","year":"2011","unstructured":"Yecies JL, Manning BD . mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med (Berl) 2011; 89: 221\u2013228.","journal-title":"J Mol Med (Berl)"},{"key":"BFonc2017349_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.26323","volume":"58","author":"M Bhat","year":"2013","unstructured":"Bhat M, Sonenberg N, Gores GJ . The mTOR pathway in hepatic malignancies. Hepatology 2013; 58: 810\u2013818.","journal-title":"Hepatology"},{"key":"BFonc2017349_CR12","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR . mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 2015; 34: 2239\u20132250.","journal-title":"Oncogene"},{"key":"BFonc2017349_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00277-010-1070-6","volume":"90","author":"P Argyriou","year":"2011","unstructured":"Argyriou P, Papageorgiou SG, Panteleon V, Psyrri A, Bakou V, Pappa V et al. Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1-HIF-1alpha pathway. Ann Hematol 2011; 90: 315\u2013322.","journal-title":"Ann Hematol"},{"key":"BFonc2017349_CR14","doi-asserted-by":"publisher","first-page":"e1010958","DOI":"10.1080\/23723556.2015.1010958","volume":"3","author":"YM Kim","year":"2016","unstructured":"Kim YM, Park JM, Grunwald D, Kim DH . An expanded role for mTORC1 in autophagy. Mol Cell Oncol 2016; 3: e1010958.","journal-title":"Mol Cell Oncol"},{"key":"BFonc2017349_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD . The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412: 179\u2013190.","journal-title":"Biochem J"},{"key":"BFonc2017349_CR16","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.1073\/pnas.1101544108","volume":"108","author":"B Herquel","year":"2011","unstructured":"Herquel B, Ouararhni K, Khetchoumian K, Ignat M, Teletin M, Mark M et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci USA 2011; 108: 8212\u20138217.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017349_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/auto.36098","volume":"11","author":"WC Shen","year":"2015","unstructured":"Shen WC, Li HY, Chen GC, Chern Y, Tu PH . Mutations in the ubiquitin-binding domain of OPTN\/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy 2015; 11: 685\u2013700.","journal-title":"Autophagy"},{"key":"BFonc2017349_CR18","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.1007\/s13277-015-3572-2","volume":"36","author":"Q Ding","year":"2015","unstructured":"Ding Q, He D, He K, Zhang Q, Tang M, Dai J et al. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers. Tumour Biol 2015; 36: 8761\u20138772.","journal-title":"Tumour Biol"},{"key":"BFonc2017349_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bbrc.2015.05.117","volume":"463","author":"Y Wang","year":"2015","unstructured":"Wang Y, He D, Yang L, Wen B, Dai J, Zhang Q et al. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis. Biochem Biophys Res Commun 2015; 463: 458\u2013465.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2017349_CR20","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","volume":"5","author":"S Menon","year":"2012","unstructured":"Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E et al. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal 2012; 5: ra24.","journal-title":"Sci Signal"},{"key":"BFonc2017349_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/hep.25989","volume":"57","author":"X Sun","year":"2013","unstructured":"Sun X, Han L, Seth P, Bian S, Li L, Csizmadia E et al. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39\/ENTPD1 null mice. Hepatology 2013; 57: 205\u2013216.","journal-title":"Hepatology"},{"key":"BFonc2017349_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2015.04.003","volume":"27","author":"AM El-Naggar","year":"2015","unstructured":"El-Naggar AM, Veinotte CJ, Cheng H, Grunewald TG, Negri GL, Somasekharan SP et al. Translational activation of HIF1alpha by YB-1 promotes sarcoma metastasis. Cancer Cell 2015; 27: 682\u2013697.","journal-title":"Cancer Cell"},{"key":"BFonc2017349_CR23","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-13-3009","volume":"74","author":"X Zhao","year":"2014","unstructured":"Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun J et al. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res 2014; 74: 2455\u20132464.","journal-title":"Cancer Res"},{"key":"BFonc2017349_CR24","first-page":"3887","volume":"7","author":"L Zhang","year":"2014","unstructured":"Zhang L, Ye SB, Li ZL, Ma G, Chen SP, He J et al. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients. Int J Clin Exp Pathol 2014; 7: 3887\u20133897.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFonc2017349_CR25","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","volume":"135","author":"A Villanueva","year":"2008","unstructured":"Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008; 135: 1972\u20131983.","journal-title":"Gastroenterology"},{"key":"BFonc2017349_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/jb\/mvt112","volume":"155","author":"D Yamada","year":"2014","unstructured":"Yamada D, Hoshii T, Tanaka S, Hegazy AM, Kobayashi M, Tadokoro Y et al. Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals. J Biochem 2014; 155: 227\u2013233.","journal-title":"J Biochem"},{"key":"BFonc2017349_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/cdd.2010.82","volume":"18","author":"YJ Kang","year":"2011","unstructured":"Kang YJ, Lu MK, Guan KL . The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis. Cell Death Differ 2011; 18: 133\u2013144.","journal-title":"Cell Death Differ"},{"key":"BFonc2017349_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/1535-7163.MCT-14-0768","volume":"14","author":"H Huynh","year":"2015","unstructured":"Huynh H, Hao HX, Chan SL, Chen D, Ong R, Soo KC et al. Loss of tuberous sclerosis complex 2 (TSC2) is frequent in hepatocellular carcinoma and Predicts response to mTORC1 inhibitor everolimus. Mol Cancer Ther 2015; 14: 1224\u20131235.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2017349_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cell.2008.07.039","volume":"134","author":"K Newton","year":"2008","unstructured":"Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134: 668\u2013678.","journal-title":"Cell"},{"key":"BFonc2017349_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s13238-012-2088-4","volume":"4","author":"M Feng","year":"2013","unstructured":"Feng M, Ding Z, Xu L, Kong L, Wang W, Jiao S et al. Structural and biochemical studies of RIG-I antiviral signaling. Protein Cell 2013; 4: 142\u2013154.","journal-title":"Protein Cell"},{"key":"BFonc2017349_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/978-1-4419-6676-6_8","volume":"54","author":"K Iwai","year":"2010","unstructured":"Iwai K . Functions of linear ubiquitin chains in the NF-kappaB pathway: linear polyubiquitin in NF-kappaB signaling. Subcell Biochem 2010; 54: 100\u2013106.","journal-title":"Subcell Biochem"},{"key":"BFonc2017349_CR32","first-page":"425","volume":"18","author":"T Chano","year":"2006","unstructured":"Chano T, Saji M, Inoue H, Minami K, Kobayashi T, Hino O et al. Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation. Int J Mol Med 2006; 18: 425\u2013432.","journal-title":"Int J Mol Med"},{"key":"BFonc2017349_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.cellsig.2008.01.020","volume":"20","author":"S Han","year":"2008","unstructured":"Han S, Witt RM, Santos TM, Polizzano C, Sabatini BL, Ramesh V . Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC\/mTOR signaling. Cell Signal 2008; 20: 1084\u20131091.","journal-title":"Cell Signal"},{"key":"BFonc2017349_CR34","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1101\/gad.1624008","volume":"22","author":"J Hu","year":"2008","unstructured":"Hu J, Zacharek S, He YJ, Lee H, Shumway S, Duronio RJ et al. WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase. Genes Dev 2008; 22: 866\u2013871.","journal-title":"Genes Dev"},{"key":"BFonc2017349_CR35","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1074\/jbc.C500451200","volume":"281","author":"H Chong-Kopera","year":"2006","unstructured":"Chong-Kopera H, Inoki K, Li Y, Zhu T, Garcia-Gonzalo FR, Rosa JL et al. TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J Biol Chem 2006; 281: 8313\u20138316.","journal-title":"J Biol Chem"},{"key":"BFonc2017349_CR36","doi-asserted-by":"crossref","first-page":"36185","DOI":"10.18632\/oncotarget.9154","volume":"7","author":"X Ma","year":"2016","unstructured":"Ma X, Guo P, Qiu Y, Mu K, Zhu L, Zhao W et al. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway. Oncotarget 2016; 7: 36185\u201336197.","journal-title":"Oncotarget"},{"key":"BFonc2017349_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/labinvest.2015.63","volume":"95","author":"Q Wei","year":"2015","unstructured":"Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai W et al. Estrogen suppresses hepatocellular carcinoma cells through ERbeta-mediated upregulation of the NLRP3 inflammasome. Lab Invest 2015; 95: 804\u2013816.","journal-title":"Lab Invest"},{"key":"BFonc2017349_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 2014; 94: 52\u201362.","journal-title":"Lab Invest"},{"key":"BFonc2017349_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11302-013-9369-0","volume":"9","author":"Q Wei","year":"2013","unstructured":"Wei Q, Zhang Y, Sun L, Jia X, Huai W, Yu C et al. High dose of extracellular ATP switched autophagy to apoptosis in anchorage-dependent and anchorage-independent hepatoma cells. Purinergic Signal 2013; 9: 585\u2013598.","journal-title":"Purinergic Signal"},{"key":"BFonc2017349_CR40","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1038\/srep06248","volume":"4","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Li T, Guo P, Kang J, Wei Q, Jia X et al. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci Rep 2014; 4: 6248.","journal-title":"Sci Rep"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2017349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2017349","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/onc2017349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:02:14Z","timestamp":1684472534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFonc2017349"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.349","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]},"assertion":[{"value":"14 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}